CD4 + IL-4 + cells | CD8 + IL-4 + cells | CD4 + IFN-γ + cells | CD8 + IFN-γ + cells | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Before treatment | After treatment | Controls | Before treatment | After treatment | Controls | Before treatment | After treatment | Controls | Before treatment | After treatment | Controls | |
Resting phase | 1.39 (0.21) | 1.27 (0.18) | 0.55 (0.15) | 2.64 (1.10) | 1.76 (0.38) | 0.77 (0.26) | 1.51 (0.32) | 1.54 (0.31) | 0.68 (0.20) | 1.36 (0.51) | 1.64 (0.19) | 0.91 (0.21) |
PMA/iono immunostimulation | 1.91 (0.62) | 1.29 (0.29) | 0.64 (0.17) | 2.82 (1.37) | 1.74 (0.58) | 0.76 (0.24) | 3.91 (1.05) | 4.16 (1.01) | 2.27 (0.90) | 5.63 (1.55) | 5.66 (1.48) | 1.80 (0.76) |
LSA immunostimulation | 3.34 (1.70) | 1.55 (0.38) | 0.60 (0.14) | 5.08 (1.81) | 2.03 (0.42) | 0.67 (0.32) | 3.49 (1.26) | 3.02 (0.83) | 0.58 (0.20) | 4.65 (1.37) | 3.86 (0.67) | 0.59 (0.13) |